A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 162 participants.

Also called NCT03950843

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 162 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03950843
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03950843. Randomized; double masking; primary purpose treatment. Start 2019-04-23 (actual); primary completion 2021-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
Intervention (Drug)
CKD-825
Intervention (Drug)
Placebo oral capsule
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct03950843
Content hash
4b1590188568bdd618cea736e4a5e1a5f30d39fc610f9cdf22c792fe0ad5e3db